For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This report studies the Hydroxyapatite market, from angles of players, regions, product types and end industries, to analyze the status and the future. Hydroxyapatite (HAp) is a calcium phosphate similar to the human hard tissues in morphology and composition. Particularly, it has a hexagonal structure and a stoichiometric Ca/P ratio of 1.67, which is identical to bone apatite.
Hydroxyapatite is chemically similar to the mineral component of bones and hard tissues in mammals. It is one of few materials that are classed as bioactive, meaning that it will support bone ingrowth and osseointegration when used in orthopaedic, dental and maxillofacial applications.
Scope of the Report:
This report focuses on the Hydroxyapatite in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
At present, the major manufacturers of Hydroxyapatite are concentrated in SofSera, Fluidinova, Bio-Rad, Bonesupport AB, Sigma Graft, Berkeley Advanced Biomaterials, etc. SofSera is the world leader.
Hydroxyapatite is the most widely accepted biomaterial for the repair and reconstruction of bone tissue defects. It has all the characteristic features of biomaterials. So hydroxyapatite downstream is wide and recently Hydroxyapatite has acquired increasing significance in various fields of Orthopaedic, Dental, Biochemical Research and others.
In the future, United States market is expected to witness significant growth on account of rising applications, so in the next few years, Hydroxyapatite production will show a trend of steady growth. In 2024 the production of Hydroxyapatite is estimated to be 17988 Kg. On product prices, the slow upward trend in recent years will maintain in the future.
The worldwide market for Hydroxyapatite is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Bonesupport AB
- GE Healthcare
- Sigma Graft
- Berkeley Advanced Biomaterials
- Zimmer Biomet
- Nano Interface Technology
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Medical Grade Hydroxyapatite (HAP)
- Research Grade Hydroxyapatite (HAP)
Market Segment by Applications, can be divided into
- Biochemical Research
There are 15 Chapters to deeply display the global Hydroxyapatite market.
Chapter 1, to describe Hydroxyapatite Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hydroxyapatite, with sales, revenue, and price of Hydroxyapatite, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hydroxyapatite, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hydroxyapatite market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hydroxyapatite sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source